Dialysis adequacy and kinetics

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 599-605

  Daugirdas, John T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; UREA;

ACUTE KIDNEY FAILURE; BODY SIZE; CALCULATION; CREATININE CLEARANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTENSIVE CARE UNIT; MOLECULAR WEIGHT; PARENTERAL NUTRITION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

APPOINTMENTS AND SCHEDULES; BETA 2-MICROGLOBULIN; CIRCADIAN RHYTHM; HUMANS; KINETICS; MODELS, THEORETICAL; PARENTERAL NUTRITION; PERITONEAL DIALYSIS; RENAL DIALYSIS; UREA;

EID: 0033709693     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00003     Document Type: Review

References (34)

1. Lessons from the Hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis dose
2. Mouse to elephant: Biological scaling and Kt/V
3. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn
4. Dose of hemodialysis and survival: Differences by race and sex
5. Exploring the reverse J-shaped curve between urea reduction ratio and mortality
6. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients
7. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose
8. Obesity and mortality in ESRD: Is it good to be fat?
9. Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose
10. Body size, dose of hemodialysis, and mortality
11. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation
12. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation
13. Survival advantage in Asian American end-stage renal disease patients
14. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis
15. Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group
16. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
17. The equivalent renal urea clearance: A new parameter to assess dialysis dose
18. The current place of urea kinetic modelling with respect to different dialysis modalities
19. Modeling the dose of home dialysis
20. Noncompliance in hemodialysis: Predictors and survival analysis
21. An international study of patient compliance with hemodialysis
22. Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates
23. Effect of intradialytic parenteral nutrition on delivered Kt/V
24. Significant reduction of delivered Kt/V by food intake during hemodialysis [abstract]
25. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel
26. Serial use of dialyzers in large patients to improve urea reduction ratio (URR) and Kt/V
27. Measurement of the delivery of dialysis in acute renal failure
28. Relationship between apparent (single-pool) and true (double-pool) urea distribution volume
29. Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group
30. Dose of intermittent hemodialysis (IHD) and outcome of acute renal failure (ART): A prospective randomized study
31. Biocompatible membranes in acute renal failure: Prospective case-controlled study
32. Effect of the dialysis membrane in the treatment of patients with acute renal failure
33. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial. International Multicentre Study Group